Announcement
08 Sep 2017
In September 2017, the European Investment Bank (EIB) signed a loan agreement with Evotec AG to support its Innovate strategy concerning its drug discovery and development services for pharmaceutical and biotech companies. The loan will be guaranteed by the European Fund for Strategic Investment (EFSI).
Source
Number of interventions
2
2 certainly harmful
0 likely harmful
0 liberalising
Implementation date
08 Sep 2017
Revocation date:
No revocation date
The EIB's loan to Evotec AG signed on 8 September 2017 was issued under the European Fund for Strategic Investment (EFSI). The loan has a total value of EUR 75 million (approx. USD 90.3 million) an...
The loan agreement between the European Investment Bank (EIB) and Evotec AG was signed on 8 September 2017 and has a total value of EUR 75 million (approx. USD 90.3 million).
The loan ...
See all
This state act is not part of any Thread yet.